迈瑞医疗收盘下跌1.04%，滚动市盈率25.49倍，总市值2839.30亿元

Group 1 - The core viewpoint of the articles highlights that Mindray Medical's stock closed at 234.18 yuan, down 1.04%, with a rolling PE ratio of 25.49 times and a total market capitalization of 283.93 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 59.49 times and a median of 40.19 times, Mindray Medical ranks 51st [1] - The net outflow of main funds for Mindray Medical on August 19 was 8.04 million yuan, with a total outflow of 7.57 million yuan over the past five days [1] Group 2 - Mindray Medical's main business includes the research, manufacturing, marketing, and service of medical devices, with key products in life information and support, in vitro diagnostics, medical imaging, electrophysiology, and vascular intervention [1] - The latest quarterly report for Q1 2025 shows that the company achieved operating revenue of 8.24 billion yuan, a year-on-year decrease of 12.12%, and a net profit of 2.63 billion yuan, down 16.81%, with a gross profit margin of 62.53% [1] - The PE ratios for Mindray Medical are 25.49 (TTM) and 24.33 (static), with a price-to-book ratio of 7.36 [2]